Search

everythinglearnresearchcommunity

for

Search:↓

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Some topical treatments like corticosteroids and vitamin D analogues are effective for scalp psoriasis, but more long-term data is needed.

Trichoscopy is a useful, painless tool for diagnosing and monitoring children's hair and scalp issues.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Most patients with systemic lupus erythematosus in Malwa, India, show skin symptoms like photosensitivity and rashes.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

Early and accurate diagnosis of posterior scalp hair loss is crucial for effective treatment and better outcomes.

Hair transplants can rarely cause scalp inflammation leading to hair loss, needing early detection and treatment.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

The document concludes that specific dermoscopic features can help diagnose different facial red skin conditions.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.